Digital Health Global
APRIL 25, 2024
By combining NYPC’s expertise in proton beam radiotherapy with Koneksa’s advanced remote monitoring solutions, the results from this study will advance our understanding of how patient-generated health data can improve radiotherapy treatment protocols in lung cancer.”
Health Populi
JULY 26, 2022
We can see the Amazon column (second in alpha order following Alibaba) with more checkmarks (in dots) indicating the most health care activities by type compared with any other “tech giant” in the world. ” I added the bold emphasis here on the issue of personal health data.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Populi
APRIL 24, 2019
I analyzed those general results with health/care implications here in Health Populi. In this study, the healthcare industry is comprised of five segments: hospitals and clinics; pharma; biotech (separate from pharma); consumer health (e.g., over-the-counter medicines); and, health insurance.
Health Populi
NOVEMBER 12, 2019
“Google’s ‘Project Nightingale’ Gathers Personal Health Data on Millions of Americans,” the Wall Street Journal reported in today’s paper and on the WSJ.com website. health care. ” Note: this release was written after the Wall Street Journal published this story.
Insulin Nation
JULY 29, 2014
A group of European health regulators have recommended the approval of a drug treatment that combines long-lasting insulin with a drug that promotes insulin secretion. The process also was used to prevent a form of blindness in the whiskered test subjects, according to an article in Fierce Biotech Research. Social Creatures.
Lloyd Price
AUGUST 23, 2023
Health management tools: Patients can use health management tools to track their health data and set goals. In 2019, Alibaba Health partnered with the University Hospital of Leuven in Belgium to develop a digital health platform for patients with chronic diseases.
Health Populi
MAY 30, 2018
These concerns fall into the buckets of health insurance coverage, or lack thereof; insurance denials; affordability for the breakthrough therapies; and, potential risks of future denials for insurance based on the patient’s personalized genomic or other health data.
Expert insights. Personalized for you.
88 
Let's personalize your content